Researchers successfully detect lung cancer in more than 80% of liver cancers in a new study of 724 people at Johns Hopkins Cancer Center.

An AI-based home screening test to detect oral and throat cancers from saliva samples is now available in the United States .

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality.

Current screening tools are imperfect and sometimes misleading; using additional genetic analysis can help physicians be more accurate.

An AI-based home screening test to detect oral and throat cancers from saliva samples is now available in the United States

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

An AI-based home screening test to detect oral and throat cancers from saliva samples is now available in the United States.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

As a "breakthrough device," the saliva test can detect early symptoms of oral and throat cancer with more than 90 percent accuracy.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

Michigan State research shows insects can differentiate between cancer cells and healthy cells, which could help detect the disease earlier

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer

Today, scientists report a device that uses the tiny worms to detect lung cancer cells and could help diagnose cancer at an earlier stage.

Cancer detection is a major public health challenge, and the methods currently available to achieve it are often expensive and invasive.

A blood test, combined with a risk model based on an individual’s history, more accurately determines who will benefit from screenings.